Meribel Pharma Solutions

Meribel Pharma Solutions is a leading European Contract Development and Manufacturing Organization (CDMO) headquartered in the UK, with 13 sites across 45, 141, and 145. Formed through the strategic integration of Synerlab and Recipharm facilities, Meribel combines decades of expertise to provide comprehensive pharmaceutical services across sterile multidose, lyophilized products, sachets, stick packs, oral solid, semi-solid, and liquid dosage forms. The company offers end-to-end solutions from drug development to commercial manufacturing, ensuring high-quality production with adherence to EU GMP and global regulatory standards. Meribel Pharma Solutions is recognized for its expertise in developing innovative formulations, optimizing manufacturing processes, and delivering reliable, scalable solutions tailored to the needs of pharmaceutical and biotech clients. Committed to quality, innovation, and sustainability, Meribel integrates advanced technology and regulatory compliance into every project, helping clients bring safe, effective, and market-ready products to patients worldwide. Its focus on scientific excellence and operational reliability makes Meribel Pharma Solutions a trusted partner for pharmaceutical development and manufacturing across Europe and beyond.